ANNOVIS BIO INC's ticker is ANVS and the CUSIP is 03615A108. A total of 28 filers reported holding ANNOVIS BIO INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $323,419 | -33.5% | 34,080 | +0.2% | 0.12% | -27.2% |
Q2 2023 | $486,003 | -53.6% | 34,010 | -50.0% | 0.16% | -12.7% |
Q1 2023 | $1,048,188 | +129.5% | 68,020 | +100.0% | 0.18% | +10.4% |
Q4 2022 | $456,754 | +82.7% | 34,010 | +331.7% | 0.16% | +110.3% |
Q3 2021 | $250,000 | -62.3% | 7,878 | +1.7% | 0.08% | -59.8% |
Q2 2021 | $663,000 | – | 7,750 | – | 0.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wescott Financial Advisory Group, LLC | 41,607 | $1,321,000 | 0.75% |
AIGH Capital Management LLC | 66,469 | $2,110,000 | 0.44% |
Worth Venture Partners, LLC | 19,878 | $631,000 | 0.28% |
Knoll Capital Management, LLC | 14,210 | $451,000 | 0.22% |
Sterling Investment Advisors, Ltd. | 14,474 | $460,000 | 0.14% |
Essex LLC | 11,962 | $380,000 | 0.10% |
Redmond Asset Management, LLC | 7,878 | $250,000 | 0.08% |
Modera Wealth Management, LLC | 33,298 | $1,057,000 | 0.05% |
Virtus ETF Advisers LLC | 2,387 | $76,000 | 0.03% |
Virtu Financial LLC | 11,547 | $367,000 | 0.03% |